Understanding factors influencing health outcomes of drug-resistant tuberculosis (DR-TB) patients attending the Programmatic Management of Drug-Resistant Tuberculosis (PMDT) model of care in Pakistan - Dr Shazra Abbas
Drug-Resistant tuberculosis (DR-TB) is a complex form of TB that develops when the causative bacteria (Mycobacterium tuberculosis) become resistant to anti-TB drugs used for the treatment of primary TB. A rise in DR-TB reflects a weak health system's response to primary TB. Pakistan is ranked fifth for primary TB and fourth for DR-TB incidence in the world.
Follow Dr Abbas' work: